Selective Serotonin Reuptake Inhibitors (SSRIs)
First line of treatment for depression.
Block the reuptake of serotonin, increasing its availability in the synapse.
Examples: Pristiq, Cymbalta, Effexor (the last two are also SNRIs).
Common withdrawal symptoms include brain zaps and emotional disturbances.
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Similar to SSRIs, but also block norepinephrine reuptake, impacting mood and energy.
More likely to produce withdrawal symptoms compared to SSRIs.
Tricyclic Antidepressants (TCAs)
Block reuptake of serotonin and norepinephrine plus other neurotransmitters, including histamine.
Example: Tofranil.
Used primarily for patients showing resistance to SSRIs.
Monoamine Oxidase Inhibitors (MAOIs)
Prevent breakdown of neurotransmitters, including serotonin, norepinephrine, and dopamine.
Can cause hypertension and require dietary restrictions.
Typically used as a last resort.
Wellbutrin
Targets dopamine, used for mood regulation, smoking cessation, and in conjunction with low-dose naltrexone for weight loss.
Particularly effective for patients with low motivation related to depression.
Prevalence
Approximately 16% of adults in the US experience depression in their lifetime.
Key Symptoms
Sadness or emotional numbness.
Loss of interest or pleasure in previous enjoyable activities.
Additional symptoms: worthlessness, sleep disturbances, concentration issues.
Chemical Misconception
The oversimplified notion that depression is merely due to low serotonin levels is misleading.
Antidepressant efficacy can vary; SSRIs may take weeks before improvement is noticeable.
Neurotransmitter Complexity
Depression is not solely linked to serotonin; other neurotransmitters affect mood.
Structural brain changes (e.g., amygdala, hippocampus) are observed in some depressed patients.
Genetic Influences
Evidence suggests depression can be familial but is complex in its genetic associations.
Environmental factors, particularly childhood trauma, contribute significantly to adult depression.
Depression can lead to a repetitive cycle involving:
Stressors → Negative thoughts → Specific emotions → Behavioral responses (e.g., avoiding social interactions) → Stressors repeat.
Cognitive Behavioral Therapy (CBT)
Focuses on identifying and altering negative thoughts and behaviors impacting emotional well-being.
Worksheets and tracking emotions assist clients in recognizing thought patterns.
Behavioral Activation
Encourages engagement in pleasurable activities to offset depressive symptoms.
Often requires support from others for accountability.
Interpersonal Therapy
Emphasizes managing interpersonal relationships and coping skills rather than analyzing the root of depression.
Multimodal Treatment
Combining medication with psychological therapies demonstrates higher efficacy in treating depression and bipolar disorder.
Treatment can be concurrent (both therapy and medication) or sequential (one after another).
Medication
Lithium and mood stabilizers (like Depakote) are first-line treatments for bipolar disorder.
Important for patients to track moods and medication adherence due to the dynamic nature of their condition.
Challenges
Access to mental health care and medication adjustments frequently proves problematic, exacerbating untreated mental illness.
Childhood Trauma and Mental Health
Trauma in childhood increases vulnerability to depression and other mental health disorders later in life.
Adverse childhood experiences (ACEs) have been linked to various health issues, including fibromyalgia.
Emotional Awareness
Identifying emotions and understanding their implications can guide boundary setting and coping mechanisms.
Tools like an emotion wheel help clients decode and manage their feelings effectively.
Mindfulness Practices
Techniques like STOP (Step back, Take a moment, Observe, Proceed mindfully) can drastically improve emotional responses to negative situations.
Final Thoughts
Mental health struggles are complex, and understanding the interplay of genetics, environment, and brain chemistry is fundamental in developing therapeutic strategies.